| Item Type | Name |
|
Concept
|
Breast Neoplasms
|
|
Academic Article
|
Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling.
|
|
Academic Article
|
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.
|
|
Academic Article
|
Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients.
|
|
Academic Article
|
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.
|
|
Academic Article
|
Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy.
|
|
Academic Article
|
Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?
|
|
Academic Article
|
Genome-wide association study of epirubicin-induced leukopenia in Japanese patients.
|
|
Academic Article
|
Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials.
|
|
Academic Article
|
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
|
|
Academic Article
|
Re: CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the Breast International Group 1-98 trial.
|
|
Academic Article
|
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration.
|
|
Academic Article
|
Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen response.
|
|
Academic Article
|
Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients.
|
|
Academic Article
|
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.
|
|
Academic Article
|
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression.
|
|
Academic Article
|
Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapy.
|
|
Academic Article
|
Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
|
|
Academic Article
|
Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis.
|
|
Academic Article
|
Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
|
|
Academic Article
|
Involvement of C12orf32 overexpression in breast carcinogenesis.
|
|
Academic Article
|
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.
|
|
Academic Article
|
Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis.
|
|
Academic Article
|
Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
|
|
Academic Article
|
Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells.
|
|
Academic Article
|
PKIB expression strongly correlated with phosphorylated Akt expression in breast cancers and also with triple-negative breast cancer subtype.
|
|
Academic Article
|
A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese.
|
|
Academic Article
|
CYP2D6 genotype and tamoxifen activity: understanding interstudy variability in methodological quality.
|
|
Academic Article
|
Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis.
|
|
Academic Article
|
Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells.
|
|
Academic Article
|
Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
|
|
Academic Article
|
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.
|
|
Academic Article
|
Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies.
|
|
Academic Article
|
ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.
|
|
Academic Article
|
Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.
|
|
Academic Article
|
Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.
|
|
Academic Article
|
Critical involvement of RQCD1 in the EGFR-Akt pathway in mammary carcinogenesis.
|
|
Academic Article
|
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.
|
|
Academic Article
|
Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.
|
|
Academic Article
|
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells.
|
|
Academic Article
|
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.
|
|
Academic Article
|
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
|
|
Academic Article
|
Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.
|
|
Academic Article
|
A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients.
|
|
Academic Article
|
Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.
|
|
Academic Article
|
Genome-wide association study of breast cancer in the Japanese population.
|
|
Academic Article
|
Enhanced SMYD3 expression is essential for the growth of breast cancer cells.
|
|
Academic Article
|
Critical roles of T-LAK cell-originated protein kinase in cytokinesis.
|
|
Academic Article
|
VAV3 mediates resistance to breast cancer endocrine therapy.
|
|
Academic Article
|
A rare polymorphic variant of NBS1 reduces DNA repair activity and elevates chromosomal instability.
|
|
Academic Article
|
Identification of semaphorin3B as a direct target of p53.
|
|
Academic Article
|
Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers.
|
|
Academic Article
|
PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
|
|
Academic Article
|
Re: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.
|
|
Academic Article
|
Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells.
|
|
Academic Article
|
Germline PARP4 mutations in patients with primary thyroid and breast cancers.
|
|
Academic Article
|
Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers.
|
|
Academic Article
|
Cystatin C as a p53-inducible apoptotic mediator that regulates cathepsin L activity.
|
|
Academic Article
|
Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy.
|
|
Academic Article
|
Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors.
|
|
Academic Article
|
Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study.
|
|
Academic Article
|
Characteristics and prognosis of Japanese female breast cancer patients: The BioBank Japan project.
|
|
Academic Article
|
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
|
|
Academic Article
|
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer.
|
|
Academic Article
|
Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
|
|
Academic Article
|
Breast cancer: The translation of big genomic data to cancer precision medicine.
|
|
Academic Article
|
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM.
|
|
Academic Article
|
Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population.
|
|
Academic Article
|
The GALNT6-LGALS3BP axis promotes breast cancer cell growth.
|
|
Academic Article
|
Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer.
|
|
Academic Article
|
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer.
|
|
Academic Article
|
Neoantigens elicit T cell responses in breast cancer.
|
|
Academic Article
|
Functional genomics for breast cancer drug target discovery.
|
|
Academic Article
|
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.
|